BIOMAT Database Logo BIOMAT Database Logo

Nephrotic syndrome: Efficacy of rituximab in challenging nephrotic syndrome. 2015

Kevin V Lemley, and Robert H Mak
Division of Paediatric Nephrology, Children's Hospital Los Angeles, University of Southern California, 4650 Sunset Boulevard, Los Angeles, CA 90027, USA.

A new trial provides further evidence that rituximab treatment can reduce the risk of relapse in children with steroid-dependent idiopathic nephrotic syndrome. Addition of a single infusion of rituximab to steroid therapy was associated with a decrease in proteinuria at 3 months and a significant increase in the relapse-free period.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D008297 Male Males
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

Kevin V Lemley, and Robert H Mak
Efficacy of rituximab therapy against intractable steroid-resistant nephrotic syndrome.
October 2016, Pediatrics international : official journal of the Japan Pediatric Society,
Kevin V Lemley, and Robert H Mak
Nephrotic syndrome: Rituximab in childhood steroid-dependent nephrotic syndrome.
October 2013, Nature reviews. Nephrology,
Kevin V Lemley, and Robert H Mak
Rituximab in refractory nephrotic syndrome.
March 2010, Pediatric nephrology (Berlin, Germany),
Kevin V Lemley, and Robert H Mak
Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome.
February 2012, Pediatric nephrology (Berlin, Germany),
Kevin V Lemley, and Robert H Mak
Rituximab in steroid-dependent nephrotic syndrome.
November 2013, Iranian journal of kidney diseases,
Kevin V Lemley, and Robert H Mak
Rituximab for nephrotic syndrome in children.
April 2017, Clinical and experimental nephrology,
Kevin V Lemley, and Robert H Mak
Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
January 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Kevin V Lemley, and Robert H Mak
Effectiveness of rituximab in nephrotic syndrome treatment.
January 2017, Central-European journal of immunology,
Kevin V Lemley, and Robert H Mak
The efficacy of rituximab in the treatment of refractory nephrotic syndrome: a meta-analysis.
June 2020, International urology and nephrology,
Kevin V Lemley, and Robert H Mak
Rituximab for steroid-dependent nephrotic syndrome.
October 2010, Clinical nephrology,
Copied contents to your clipboard!